Table 3.

The plasma level(s) of TNF-α, IL6, IL1ß, IL18, and CRP

Inflammatory factors	Control	PCOS	TE+SPE50	TE+SPE200	TE+SPE600
TNF-α	293±3.21	373±2.10 #	355±2.21 *	348±3.07 ***	330±6.83 ***
IL-6	101±1.15	241±8.72 #	201±10.46 **	183±5.57 ***	171±8.72 ***
IL-1ß	31.66±0.84	59.50±0.34 #	55.33±1.17 *	54.16±0.87 ***	54±0.99 ***
IL-18	316±10.54	410±8.56 #	363±9.18 **	338±6 ***	336±4.21 ***
CRP	0.17±0.0004	0.32±0.0008 #	0.28±0.012 **	0.26±0.007 ***	0.21±0.10 ***

Plasma TNF-α, IL6, IL1ß, IL18, and CRP level(s) were measured by using an ELISA kit. In PCOS groups treated with SPE, a significant reduction in levels of inflammatory factors (TNF-α, IL-6, IL-1ß, IL18, and CRP) was observed. All values are presented as the means±SEMs (n=12 per group).

TE, Testosterone enanthate; # p<0.001 vs. control, *** p<0.001, ** p<0.01, * p<0.05 vs. TE